**Core Concept**
HMB-45 is a monoclonal antibody that targets an antigen present in melanocytic tumors, specifically in melanoma cells. This antibody is used as a diagnostic marker to identify melanomas and their metastases.

**Why the Correct Answer is Right**
HMB-45 reacts with an antigen known as gp100, which is a melanocyte-specific protein. This protein is a subunit of the enzyme tyrosinase, which plays a crucial role in melanin synthesis. By targeting gp100, HMB-45 helps to identify melanoma cells, which express this antigen. This is particularly useful in distinguishing melanoma from other types of skin tumors.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because HMB-45 is not a marker for carcinoid tumors; those are typically identified using antibodies against chromogranin A or synaptophysin.
**Option B:** This option is incorrect because HMB-45 is not a marker for lymphoma; those are typically identified using antibodies against CD markers such as CD20 or CD30.
**Option C:** This option is incorrect because HMB-45 is not a marker for hepatocellular carcinoma; those are typically identified using antibodies against alpha-fetoprotein (AFP) or other tumor markers.

**Clinical Pearl / High-Yield Fact**
HMB-45 is a valuable diagnostic tool in the workup of patients with suspected melanoma, particularly when combined with other diagnostic modalities such as clinical examination and imaging studies.

**Correct Answer:** C. Melanoma.